BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26454216)

  • 1. Interplay between menin and Dnmt1 reversibly regulates pancreatic cancer cell growth downstream of the Hedgehog signaling pathway.
    Cheng P; Wang YF; Li G; Yang SS; Liu C; Hu H; Jin G; Hu XG
    Cancer Lett; 2016 Jan; 370(1):136-44. PubMed ID: 26454216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c.
    Karnik SK; Hughes CM; Gu X; Rozenblatt-Rosen O; McLean GW; Xiong Y; Meyerson M; Kim SK
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14659-64. PubMed ID: 16195383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
    Lindberg D; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
    Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
    Cancer Res; 2006 Jun; 66(11):5707-15. PubMed ID: 16740708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
    Milne TA; Hughes CM; Lloyd R; Yang Z; Rozenblatt-Rosen O; Dou Y; Schnepp RW; Krankel C; Livolsi VA; Gibbs D; Hua X; Roeder RG; Meyerson M; Hess JL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):749-54. PubMed ID: 15640349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor.
    Ishida E; Yamada M; Horiguchi K; Taguchi R; Ozawa A; Shibusawa N; Hashimoto K; Satoh T; Yoshida S; Tanaka Y; Yokota M; Tosaka M; Hirato J; Yamada S; Yoshimoto Y; Mori M
    Endocr J; 2011; 58(4):287-96. PubMed ID: 21441703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy.
    Zhan Q; Fang Y; Deng X; Chen H; Jin J; Lu X; Peng C; Li H; Shen B
    Cancer Invest; 2015; 33(7):267-75. PubMed ID: 25950085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
    Lindberg D; Akerström G; Westin G
    Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
    Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
    Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
    Horiguchi K; Yamada M; Satoh T; Hashimoto K; Hirato J; Tosaka M; Yamada S; Mori M
    Clin Cancer Res; 2009 Apr; 15(8):2620-9. PubMed ID: 19318494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
    Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
    Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p27
    Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
    J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.
    Gurung B; Feng Z; Iwamoto DV; Thiel A; Jin G; Fan CM; Ng JM; Curran T; Hua X
    Cancer Res; 2013 Apr; 73(8):2650-8. PubMed ID: 23580576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis.
    Joshi PP; Kulkarni MV; Yu BK; Smith KR; Norton DL; van Veelen W; Höppener JW; Franklin DS
    Oncogene; 2007 Jan; 26(4):554-70. PubMed ID: 16953232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menin directly represses Gli1 expression independent of canonical Hedgehog signaling.
    Gurung B; Feng Z; Hua X
    Mol Cancer Res; 2013 Oct; 11(10):1215-22. PubMed ID: 23928057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global expression profiling of murine MEN1-associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling.
    Mould AW; Duncan R; Serewko-Auret M; Loffler KA; Biondi C; Gartside M; Kay GF; Hayward NK
    Int J Cancer; 2007 Aug; 121(4):776-83. PubMed ID: 17455252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation.
    Liu CC; Lin JH; Hsu TW; Su K; Li AF; Hsu HS; Hung SC
    Int J Cancer; 2015 Feb; 136(3):547-59. PubMed ID: 24947242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.